Cooper EBITDA 2012-2025 | COO
Cooper annual and quarterly EBITDA history from 2012 to 2025. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
- Cooper EBITDA for the quarter ending July 31, 2025 was $0.271B, a 3.69% decline year-over-year.
- Cooper EBITDA for the twelve months ending July 31, 2025 was $1.111B, a 8.93% increase year-over-year.
- Cooper 2024 annual EBITDA was $1.081B, a 19.98% increase from 2023.
- Cooper 2023 annual EBITDA was $0.901B, a 5.52% increase from 2022.
- Cooper 2022 annual EBITDA was $0.854B, a 4.74% increase from 2021.
|
Cooper Annual EBITDA (Millions of US $) |
|
|---|---|
| 2024 | $1,081 |
| 2023 | $901 |
| 2022 | $854 |
| 2021 | $815 |
| 2020 | $599 |
| 2019 | $828 |
| 2018 | $678 |
| 2017 | $618 |
| 2016 | $522 |
| 2015 | $428 |
| 2014 | $445 |
| 2013 | $431 |
| 2012 | $395 |
| 2011 | $326 |
|
Cooper Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2025-07-31 | $271 |
| 2025-04-30 | $277 |
| 2025-01-31 | $273 |
| 2024-10-31 | $289 |
| 2024-07-31 | $282 |
| 2024-04-30 | $260 |
| 2024-01-31 | $250 |
| 2023-10-31 | $228 |
| 2023-07-31 | $246 |
| 2023-04-30 | $187 |
| 2023-01-31 | $239 |
| 2022-10-31 | $193 |
| 2022-07-31 | $222 |
| 2022-04-30 | $226 |
| 2022-01-31 | $213 |
| 2021-10-31 | $206 |
| 2021-07-31 | $180 |
| 2021-04-30 | $221 |
| 2021-01-31 | $209 |
| 2020-10-31 | $177 |
| 2020-07-31 | $143 |
| 2020-04-30 | $97 |
| 2020-01-31 | $182 |
| 2019-10-31 | $217 |
| 2019-07-31 | $213 |
| 2019-04-30 | $218 |
| 2019-01-31 | $180 |
| 2018-10-31 | $193 |
| 2018-07-31 | $185 |
| 2018-04-30 | $144 |
| 2018-01-31 | $157 |
| 2017-10-31 | $156 |
| 2017-07-31 | $160 |
| 2017-04-30 | $163 |
| 2017-01-31 | $139 |
| 2016-10-31 | $122 |
| 2016-07-31 | $152 |
| 2016-04-30 | $138 |
| 2016-01-31 | $111 |
| 2015-10-31 | $92 |
| 2015-07-31 | $104 |
| 2015-04-30 | $116 |
| 2015-01-31 | $116 |
| 2014-10-31 | $82 |
| 2014-07-31 | $129 |
| 2014-04-30 | $121 |
| 2014-01-31 | $113 |
| 2013-10-31 | $94 |
| 2013-07-31 | $125 |
| 2013-04-30 | $112 |
| 2013-01-31 | $100 |
| 2012-10-31 | $110 |
| 2012-07-31 | $105 |
| 2012-04-30 | $92 |
| 2012-01-31 | $88 |
| 2011-10-31 | $93 |
| 2011-07-31 | $77 |
| 2011-04-30 | $84 |
| 2011-01-31 | $72 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical & Dental Supplies | $13.694B | $3.895B |
| The Cooper Companies Inc, is a specialty medical device company operating on a global basis. Cooper has two business segments- CooperVision and CooperSurgical. CooperVision manufactures and sells a wide range of contact lenses. CooperVision develops manufactures and markets a broad range of single-use, two-week and monthly contact lenses, featuring advanced materials and optics. The company's products are primarily designed for solving vision challenges like astigmatism, presbyopia and ocular dryness.?CooperSurgical sells a variety of medical devices and surgical instruments that are primarily utilized by gynecologists and obstetricians. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| McKesson (MCK) | United States | $105.013B | 23.28 |
| Becton Dickinson (BDX) | United States | $50.558B | 12.36 |
| Cardinal Health (CAH) | United States | $46.756B | 22.09 |
| West Pharmaceutical Services (WST) | United States | $20.399B | 40.10 |
| Straumann Holding AG (SAUHY) | Switzerland | $19.119B | 0.00 |
| Align Technology (ALGN) | United States | $9.946B | 18.59 |
| Henry Schein (HSIC) | United States | $8.477B | 14.94 |
| Merit Medical Systems (MMSI) | United States | $5.165B | 25.40 |
| DENTSPLY SIRONA (XRAY) | United States | $2.517B | 7.38 |
| CONMED (CNMD) | United States | $1.376B | 9.83 |
| STAAR Surgical (STAA) | United States | $1.246B | 0.00 |
| Pro-Dex (PDEX) | United States | $0.106B | 12.59 |
| Lifevantage (LFVN) | United States | $0.093B | 8.81 |